Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01211_DB01558> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01211_DB01558 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01211_DB01558 label "DDI between Clarithromycin and Bromazepam - Clarithromycin, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if clarithromycin is initiated, discontinued or dose changed. Dosage adjustments may be required. [drugbank_resource:DB01211_DB01558]" assertion.
- drugbank_resource:DB01211_DB01558 identifier "drugbank_resource:DB01211_DB01558" assertion.
- drugbank_resource:DB01211_DB01558 title "DDI between Clarithromycin and Bromazepam - Clarithromycin, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if clarithromycin is initiated, discontinued or dose changed. Dosage adjustments may be required." assertion.